The North America, Europe, and Australia peanut allergy treatment market was valued at US$ 1,252.6 MN in 2022 and is forecast to reach a value of US$ 3,036.9 MN, with Growing at a CAGR Value of 11.7% between 2022 and 2030.
Market Overview:
Peanut allergies results from immune system’s overreaction to peanuts. It the foremost common food allergies. Newborns who suffer egg or eczema allergy are highly vulnerable to peanut allergy. As it is the highly common type of food allergy, people suffering from it are highly susceptible to risk of developing anaphylaxis.
Request For Sample Report (Including Full TOC, Table & Figures):
https://www.coherentmarketinsights.com/insight/request-sample/5041
Major Key players in this Market:
- DBV Technologies.
- Aimmune Therapeutics, Inc.
- Prota Therapeutics Pty Ltd.
- COUR Pharmaceuticals
- BlueWillow Biologics
- HAL Allergy B.V.
- Allergy Therapeutics PLC.
- Novartis AG
- Regeneron Pharmaceuticals, Inc.
- Vedanta Biosciences, Inc.
- Cambridge Allergy Ltd. (Camallergy)
- Angany Inc.
- Moonlight Therapeutics Inc.
- Allero Therapeutics B.V.
- Sanofi
- Johnson & Johnson
- Viatris Inc. (Mylan N.V.)
- Sun Pharmaceutical Industries Ltd.
- Bayer AG
- Aurobindo Pharma Limited.
- Astellas Pharma Inc.
- Siolta Therapeutics
- DESENTUM OY
- ALK
- Immunomic Therapeutics, Inc.
- Stallergenes Greer Ltd.
North America, Europe, and Australia peanut allergy treatment Market Segmentation:
By Drug Type :
-
- Epinephrine
- Antihistamine
- Loratadine
- Diphenhydramine
- Others
- Palforzia
- Pipeline Drugs
- Viaskin Peanut
- Ligelizumab
- CA002
- PRT120
- Dupilumab
By Route of Administration :
-
- Oral
- Parenteral
- Intranasal
- Epicutaneous
For More Information or Query or Customization Before Buying, Visit:
https://www.coherentmarketinsights.com/insight/request-customization/5041
Market Drivers:
The peanut allergy cases are rising around the world, which is likely to propel growth of the North America, Europe and Australia peanut allergy treatment market during the forecast period. For instance, in July 2021, as per the data of Allergy UK reported nearly 2% children were affected by peanut allergy in the UK. Peanut allergy is developed early in the childhood; however, it appears in mature age sometimes.
Moreover, growing number of for novel products developed for treating peanut allergy is also expected to propel growth of the North America, Europe and Australia peanut allergy treatment market over the forecast period. In January 2020 for instance, a leading biopharmaceutical organization, Aimmune Therapeutics, Inc. received approval from the U.S. Food and Drug Administration (FDA), for Palforzia, an allergen powder for peanut allergy for treating people with peanut allergy.
Impact of COVID-19:
Many countries around the world imposed stringent lockdown regulations to control the virus spread. However, it adversely impacted the health sector among various other industries. Several industrial operations were closed down during the lockdown period, which affected manufacturing, raw material supply and distribution operations negatively all over the world. As the number of COVID-19 cases were increasing rapidly, the healthcare providers faced challenges due to lack of manpower, consumables, equipment and many other resources. Due to high number of COVID-19 cases, many hospitals suspended other medical procedures to prevent the infection. Thus, the North America, Europe and Australia peanut allergy treatment market was adversely impacted by the pandemic.
Buy This Complete Business Report:
https://www.coherentmarketinsights.com/insight/buy-now/5041
Key Questions Answered:
1. What is the market size and CAGR of the North America, Europe, and Australia peanut allergy treatment Market during the forecast period?
2. How is the growing demand impacting the growth of North America, Europe, and Australia peanut allergy treatment Market shares?
3. What is the growing demand of the North America, Europe, and Australia peanut allergy treatment Market during the forecast period?
4. Who are the leading vendors in the market and what are their market shares?
5. What is the impact of the COVID-19 pandemic on the APAC North America, Europe, and Australia peanut allergy treatment Market?
Contact us:
Mr. Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
